Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo

Safety and clinical usage of newcastle disease virus in cancer therapy

Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus

Apoptin enhances the oncolytic properties of Newcastle disease virus

Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.

Oncolytic viruses for the treatment of neuroendocrine tumors

Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus

Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells

Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus

Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity